Figure 2.
Cumulative incidence of rapid estimated GFR (eGFR) loss (■, 346 cases, 1705 at risk) and of the combined end point of rapid GFR loss, incident ESRD, or death (
, 559 cases, 2323 participants at risk) in the Cardiovascular Health Study, by serum 25-hydroxyvitamin D concentration. Adjusted for age, gender, race, site, season, attained education, household income, diabetes, smoking, physical activity, antihypertensive medication use, angiotensin-converting enzyme inhibitor use, body mass index, systolic and diastolic BP, and C-reactive protein.
